Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments ofHelicobacter pyloriinfection

Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial

(2016) Jyh-Ming Liou et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Helicobacter pylorisecond-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments

(2015) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: the prevalence ofHelicobacter pyloriand the incidence of gastric cancer across Europe

(2015) S. E. Roberts et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits

(2015) David Y. Graham   GASTROENTEROLOGY

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication ofHelicobacter pyloriin the community and hospital populations: a randomised trial

(2015) Jyh-Ming Liou et al.   GUT

Hp-normogram (normo-graham) for Assessing the Outcome ofH. pyloriTherapy: Effect of Resistance, Duration, and CYP2C19 Genotype

(2015) David Y. Graham   HELICOBACTER

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study

(2015) Jyh-Ming Liou et al.   PLoS One

Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies

(2013) Michael Selgrad et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

High secondary resistance to quinolones in German Helicobacter pylori clinical isolates

(2013) Nicole Wueppenhorst et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Commentary: is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?

(2012) M. Selgrad et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Letter: the ethics of using inferior regimens in H. pylori randomised trials

(2012) D. Y. Graham et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection

(2012) Alessandro Federico et al.   GASTROENTEROLOGY

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Levofloxacin-containing Triple and Sequential Therapy or Standard Sequential Therapy as the First Line Treatment forHelicobacter pyloriEradication in China

(2012) Juan Qian et al.   HELICOBACTER

Randomized Comparison of Two Non-Bismuth-Containing Second-line Rescue Therapies for Helicobacter pylori

(2012) Seng-Kee Chuah et al.   HELICOBACTER

Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial

(2012) J.-M. Liou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2012) Jyh-Ming Liou et al.   LANCET

Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial

(2011) J.-M. Liou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genotypic Resistance inHelicobacter pyloriStrains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies

(2010) Jyh-Ming Liou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design

(2010) J. M. Liou et al.   GUT

Helicobacter pyloriInfection

(2010) Kenneth E.L. McColl   NEW ENGLAND JOURNAL OF MEDICINE

New concepts of resistance in the treatment of Helicobacter pylori infections

(2008) David Y Graham et al.   Nature clinical practice. Gastroenterology & hepatology